Skip to Content

Psychiatric Genetics

Pablo Gejman, MD, and his team at the NorthShore Research Institute have been studying the genetic patterns and molecular information of schizophrenia and other complex psychiatric disorders for many years. Through their research and through the collaboration of more than 200 other researchers as part of the Schizophrenia Psychiatric Genome-wide Associate Study (GWAS) Consortium, important implications for clinical classification of schizophrenia have been made and new targets for treatments have been uncovered.

The Center continues to conduct research and is looking for new pharmacological strategies for treatment.